Efficacy of novel drug proven in MDD study europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Roger S. McIntyre, M.D., FRCPC introduces a video program where a panel of experts in management of mood disorders discuss the role of rapid acting therapies, specifically GABAA receptor modulators in the management of major depressive disorder; highlighting their mechanism of action, clinical utility, and the on-going research efforts within this arena.
Research this week presents the most robust evidence to date that ketamine is at least as effective as electroconvulsive therapy for patients with treatment-resistant depression who do not have psychosis.